1.23
price down icon5.38%   -0.07
pre-market  Vorhandelsmarkt:  1.27   0.04   +3.25%
loading

Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.76%
18.30
18.82 18.18 16.60 16.04
Operating Income/Loss
2.76%
-18.30
-18.82 -18.18 -16.60 -16.04
Income/Loss From Continuing Operations Before Tax
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Income/Loss From Continuing Operations After Tax
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Net Income/Loss
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,340%
29.76
2.0676 25.65 19.50 19.39
Diluted Average Shares
1,340%
29.76
2.0676 25.65 19.50 19.39
Basic Earnings Per Share
7.69%
-0.56
-0.52 -0.65 -0.81 -0.79
Diluted Earnings Per Share
7.69%
-0.56
-0.52 -0.65 -0.81 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):